Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML

NCT00583102 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Slow accrual, PI left institution

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Lovastatin

Sponsor

University of Iowa